Dr. Timothy Schmidt is a faculty member of the Division of Hematology, Medical Oncology, and Palliative Care within the Department of Medicine at the University of Wisconsin-Madison. Dr. Schmidt’s clinical interest is in management of hematological malignancies, including the use of bone marrow transplantation and CAR-T cell therapy. In his clinic, he specializes in caring for patients with multiple myeloma and other plasma cell disorders including monoclonal gammopathies and amyloidosis.  He is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the International Myeloma Society.

Dr. Schmidt’s research focuses on improving outcomes for patients with multiple myeloma. He is involved in the development and conduct of early phase and cooperative group clinical trials for patients with plasma cell disorders. Dr. Schmidt is interested in differentiating patterns of disease biology that lead to variable outcomes among patients with multiple myeloma. Through outcomes research and scientific collaborations with laboratory-based researchers, Dr. Schmidt hopes to translate these findings into clinical trials that aim to clarify how treatment may be tailored for individual patients to improve survival and reduce toxicity.